ING Groep NV Sells 143 Shares of Mettler-Toledo International Inc. (NYSE:MTD)

ING Groep NV trimmed its position in shares of Mettler-Toledo International Inc. (NYSE:MTD) by 5.0% during the 4th quarter, Holdings Channel.com reports. The institutional investor owned 2,695 shares of the medical instruments supplier’s stock after selling 143 shares during the quarter. ING Groep NV’s holdings in Mettler-Toledo International were worth $3,298,000 at the end of the most recent reporting period.

Several other hedge funds also recently modified their holdings of MTD. JPMorgan Chase & Co. grew its position in Mettler-Toledo International by 14.7% during the 3rd quarter. JPMorgan Chase & Co. now owns 221,799 shares of the medical instruments supplier’s stock worth $332,634,000 after acquiring an additional 28,478 shares during the last quarter. Quest Partners LLC boosted its stake in Mettler-Toledo International by 878.1% in the third quarter. Quest Partners LLC now owns 1,027 shares of the medical instruments supplier’s stock worth $1,540,000 after purchasing an additional 922 shares in the last quarter. Allspring Global Investments Holdings LLC grew its holdings in shares of Mettler-Toledo International by 14.0% during the third quarter. Allspring Global Investments Holdings LLC now owns 1,240 shares of the medical instruments supplier’s stock worth $1,860,000 after purchasing an additional 152 shares during the last quarter. M&T Bank Corp increased its stake in shares of Mettler-Toledo International by 14.3% in the third quarter. M&T Bank Corp now owns 4,926 shares of the medical instruments supplier’s stock valued at $7,387,000 after buying an additional 615 shares in the last quarter. Finally, Nordea Investment Management AB raised its holdings in shares of Mettler-Toledo International by 29.8% in the fourth quarter. Nordea Investment Management AB now owns 105,823 shares of the medical instruments supplier’s stock valued at $129,919,000 after buying an additional 24,285 shares during the last quarter. Institutional investors and hedge funds own 95.07% of the company’s stock.

Mettler-Toledo International Stock Down 1.3 %

MTD stock opened at $1,285.67 on Friday. Mettler-Toledo International Inc. has a twelve month low of $1,142.91 and a twelve month high of $1,546.93. The company has a market cap of $26.90 billion, a P/E ratio of 31.72, a price-to-earnings-growth ratio of 3.30 and a beta of 1.13. The business’s fifty day moving average is $1,285.56 and its 200-day moving average is $1,333.50.

Mettler-Toledo International (NYSE:MTD) last released its earnings results on Thursday, February 13th. The medical instruments supplier reported $12.41 earnings per share for the quarter, beating the consensus estimate of $11.76 by $0.65. Mettler-Toledo International had a negative return on equity of 591.54% and a net margin of 22.29%. Research analysts anticipate that Mettler-Toledo International Inc. will post 42.71 earnings per share for the current fiscal year.

Insider Buying and Selling

In other Mettler-Toledo International news, insider Gerry Keller sold 600 shares of the company’s stock in a transaction that occurred on Monday, February 10th. The shares were sold at an average price of $1,351.34, for a total value of $810,804.00. Following the completion of the sale, the insider now owns 6 shares of the company’s stock, valued at approximately $8,108.04. This represents a 99.01 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. 1.94% of the stock is owned by insiders.

Analyst Ratings Changes

A number of brokerages have commented on MTD. Citigroup raised shares of Mettler-Toledo International from a “sell” rating to a “neutral” rating and increased their price objective for the stock from $1,200.00 to $1,300.00 in a report on Wednesday, December 11th. Stifel Nicolaus decreased their price target on shares of Mettler-Toledo International from $1,550.00 to $1,450.00 and set a “buy” rating on the stock in a research note on Monday, November 11th. Wolfe Research initiated coverage on shares of Mettler-Toledo International in a research report on Friday, December 13th. They issued a “peer perform” rating for the company. Wells Fargo & Company increased their price objective on Mettler-Toledo International from $1,350.00 to $1,400.00 and gave the company an “equal weight” rating in a research report on Monday, February 10th. Finally, Robert W. Baird boosted their target price on Mettler-Toledo International from $1,362.00 to $1,369.00 and gave the stock a “neutral” rating in a research report on Monday, February 10th. One investment analyst has rated the stock with a sell rating, six have issued a hold rating and three have issued a buy rating to the company’s stock. Based on data from MarketBeat.com, the company presently has a consensus rating of “Hold” and a consensus price target of $1,368.00.

About Mettler-Toledo International

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company’s laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.